GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tissue Regenix Group PLC (LSE:TRX) » Definitions » Net Margin %

Tissue Regenix Group (LSE:TRX) Net Margin % : -5.33% (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Tissue Regenix Group Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Tissue Regenix Group's Net Income for the six months ended in Dec. 2023 was £-0.65 Mil. Tissue Regenix Group's Revenue for the six months ended in Dec. 2023 was £12.16 Mil. Therefore, Tissue Regenix Group's net margin for the quarter that ended in Dec. 2023 was -5.33%.

The historical rank and industry rank for Tissue Regenix Group's Net Margin % or its related term are showing as below:

LSE:TRX' s Net Margin % Range Over the Past 10 Years
Min: -93333.33   Med: -73.07   Max: -5.81
Current: -5.81


LSE:TRX's Net Margin % is ranked better than
71.82% of 1029 companies
in the Biotechnology industry
Industry Median: -154.15 vs LSE:TRX: -5.81

Tissue Regenix Group Net Margin % Historical Data

The historical data trend for Tissue Regenix Group's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tissue Regenix Group Net Margin % Chart

Tissue Regenix Group Annual Data
Trend Jan14 Jan15 Jan16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -53.51 -75.68 -24.27 -11.01 -5.81

Tissue Regenix Group Semi-Annual Data
Jan14 Jul14 Jan15 Jul15 Jan16 Jul16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -23.98 -13.55 -8.63 -6.33 -5.33

Competitive Comparison of Tissue Regenix Group's Net Margin %

For the Biotechnology subindustry, Tissue Regenix Group's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tissue Regenix Group's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tissue Regenix Group's Net Margin % distribution charts can be found below:

* The bar in red indicates where Tissue Regenix Group's Net Margin % falls into.



Tissue Regenix Group Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Tissue Regenix Group's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-1.353/23.299
=-5.81 %

Tissue Regenix Group's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-0.648/12.162
=-5.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tissue Regenix Group  (LSE:TRX) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Tissue Regenix Group Net Margin % Related Terms

Thank you for viewing the detailed overview of Tissue Regenix Group's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tissue Regenix Group (LSE:TRX) Business Description

Traded in Other Exchanges
Address
Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY
Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.

Tissue Regenix Group (LSE:TRX) Headlines